17 (R) -Resolvin D1
17R-Resolvin D1 (17R-RvD1; AT-RvD1) is an aspirin-triggered epimer of Resolvin D1, which exhibits anti-inflammatory activity in mice and human PMNs cells[1]. 17R-Resolvin D1 specificially inhibits TRPV3 with an IC50 of 398 nM and exhibits peripheral anti-nociceptive efficacy[2].
Product Specifications
CAS Number
528583-91-7
Product Name Alternative
17 (R) -RvD1; AT-RvD1
UNSPSC
12352211
Hazard Statement
H302, H315, H319, H335
Target
TRP Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/17-r-resolvin-d1.html
Concentration
265.61 μM * 100 μL in Ethanol
Purity
99.1
Solubility
10 mM in DMSO
Smiles
CC/C=C\C[C@@H](O)/C=C/C=C\C=C\C=C\[C@@H](O)[C@@H](O)C/C=C\CCC(O)=O
Molecular Formula
C22H32O5
Molecular Weight
376.49
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Dry Ice
Storage Conditions
-80°C, protect from light
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
TRPV3
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD106 / VCAM1 (1.4C3), CF488A conjugate, 0.1mg/mL
P27 / KIP1 (SX53G8), CF488A conjugate, 0.1mg/mL
Cytokeratin 8/18 (C-51), CF488A conjugate, 0.1mg/mL
